Evolution of blood–brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies

Blood–brain barrier (BBB) strictly controls matter exchange between blood and brain, and severely limits brain penetration of systemically administered drugs, resulting in ineffective drug therapy of brain diseases. However, during the onset and progression of brain diseases, BBB alterations evolve...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Liang, Jiang, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424230/
https://www.ncbi.nlm.nih.gov/pubmed/34522589
http://dx.doi.org/10.1016/j.apsb.2020.11.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424230/
https://www.ncbi.nlm.nih.gov/pubmed/34522589
http://dx.doi.org/10.1016/j.apsb.2020.11.023

Ejemplares similares